Despite our previous observations of significant reductions in proliferation and induction of apoptosis in canine lymphoma cells treated with EZN-3042 in vitro, [49] we observed no correlation between alterations in proliferation/apoptosis assessed immunohistochemically and changes in survivin mRNA expression. This evidence concerns the gene BIRC5 and lymphoma.